[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Covid-19 Impact on Global Human Microbiome Sequencing Market Size, Status and Forecast 2020-2026

July 2020 | 134 pages | ID: C52BF5E28986EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Human Microbiome Sequencing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Microbiome Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Microbiome Sequencing market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Human Microbiome Sequencing industry.
The key players covered in this study
  • Baseclear B.V.
  • Beijing Genomics Institute (BGI) Genomics Co., Ltd
  • Charles River Laboratories International Inc.
  • Clinical Microbiomics A/S
  • Eurofins Scientific SE
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Novogene Corporation
  • OraSure Technologies, Inc.
  • Oxford Nanopore Technologies, Inc.
  • Pacific Biosciences of California, Inc.
  • QIAGEN N.V.
  • Second Genome, Inc.
  • Thermo Fisher Scientific Inc.
  • Viome, Inc.
  • CosmosID
  • Leucine Rich Bio Pvt. Ltd.
  • Microba
  • Microbiome Insights Inc.
  • Molzym GmbH & Co. KG
Market segment by Type, the product can be split into
  • Next-Generation Sequencing
  • Traditional Sequencing Technologies
  • Other
Market segment by Application, split into
  • Genome Analysis
  • Metabolome Analysis
  • Transcriptome Analysis
  • Other Omics Analysis
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Human Microbiome Sequencing status, future forecast, growth opportunity, key market and key players.
  • To present the Human Microbiome Sequencing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Human Microbiome Sequencing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Microbiome Sequencing Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Human Microbiome Sequencing Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Next-Generation Sequencing
  1.4.3 Traditional Sequencing Technologies
  1.4.4 Other
1.5 Market by Application
  1.5.1 Global Human Microbiome Sequencing Market Share by Application: 2020 VS 2026
  1.5.2 Genome Analysis
  1.5.3 Metabolome Analysis
  1.5.4 Transcriptome Analysis
  1.5.5 Other Omics Analysis
1.6 Coronavirus Disease 2019 (Covid-19): Human Microbiome Sequencing Industry Impact
  1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.6.2 Covid-19 Impact: Commodity Prices Indices
  1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Covid-19 Implications on Global Human Microbiome Sequencing Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Human Microbiome Sequencing Growth Trends by Regions
  2.2.1 Human Microbiome Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Human Microbiome Sequencing Historic Market Share by Regions (2015-2020)
  2.2.3 Human Microbiome Sequencing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Human Microbiome Sequencing Market Growth Strategy
  2.3.6 Primary Interviews with Key Human Microbiome Sequencing Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Human Microbiome Sequencing Players by Market Size
  3.1.1 Global Top Human Microbiome Sequencing Players by Revenue (2015-2020)
  3.1.2 Global Human Microbiome Sequencing Revenue Market Share by Players (2015-2020)
  3.1.3 Global Human Microbiome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Microbiome Sequencing Market Concentration Ratio
  3.2.1 Global Human Microbiome Sequencing Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Sequencing Revenue in 2019
3.3 Human Microbiome Sequencing Key Players Head office and Area Served
3.4 Key Players Human Microbiome Sequencing Product Solution and Service
3.5 Date of Enter into Human Microbiome Sequencing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Human Microbiome Sequencing Historic Market Size by Type (2015-2020)
4.2 Global Human Microbiome Sequencing Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Human Microbiome Sequencing Market Size by Application (2015-2020)
5.2 Global Human Microbiome Sequencing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA IMPACT OF COVID-19

6.1 North America Human Microbiome Sequencing Market Size (2015-2020)
6.2 Human Microbiome Sequencing Key Players in North America (2019-2020)
6.3 North America Human Microbiome Sequencing Market Size by Type (2015-2020)
6.4 North America Human Microbiome Sequencing Market Size by Application (2015-2020)

7 EUROPE IMPACT OF COVID-19

7.1 Europe Human Microbiome Sequencing Market Size (2015-2020)
7.2 Human Microbiome Sequencing Key Players in Europe (2019-2020)
7.3 Europe Human Microbiome Sequencing Market Size by Type (2015-2020)
7.4 Europe Human Microbiome Sequencing Market Size by Application (2015-2020)

8 CHINA IMPACT OF COVID-19

8.1 China Human Microbiome Sequencing Market Size (2015-2020)
8.2 Human Microbiome Sequencing Key Players in China (2019-2020)
8.3 China Human Microbiome Sequencing Market Size by Type (2015-2020)
8.4 China Human Microbiome Sequencing Market Size by Application (2015-2020)

9 JAPAN IMPACT OF COVID-19

9.1 Japan Human Microbiome Sequencing Market Size (2015-2020)
9.2 Human Microbiome Sequencing Key Players in Japan (2019-2020)
9.3 Japan Human Microbiome Sequencing Market Size by Type (2015-2020)
9.4 Japan Human Microbiome Sequencing Market Size by Application (2015-2020)

10 SOUTHEAST ASIA IMPACT OF COVID-19

10.1 Southeast Asia Human Microbiome Sequencing Market Size (2015-2020)
10.2 Human Microbiome Sequencing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Microbiome Sequencing Market Size by Type (2015-2020)
10.4 Southeast Asia Human Microbiome Sequencing Market Size by Application (2015-2020)

11 INDIA IMPACT OF COVID-19

11.1 India Human Microbiome Sequencing Market Size (2015-2020)
11.2 Human Microbiome Sequencing Key Players in India (2019-2020)
11.3 India Human Microbiome Sequencing Market Size by Type (2015-2020)
11.4 India Human Microbiome Sequencing Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19

12.1 Central & South America Human Microbiome Sequencing Market Size (2015-2020)
12.2 Human Microbiome Sequencing Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Microbiome Sequencing Market Size by Type (2015-2020)
12.4 Central & South America Human Microbiome Sequencing Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 Baseclear B.V.
  13.1.1 Baseclear B.V. Company Details
  13.1.2 Baseclear B.V. Business Overview and Its Total Revenue
  13.1.3 Baseclear B.V. Human Microbiome Sequencing Introduction
  13.1.4 Baseclear B.V. Revenue in Human Microbiome Sequencing Business (2015-2020))
  13.1.5 Baseclear B.V. Recent Development and Reaction to COVID-19
13.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
  13.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Details
  13.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Business Overview and Its Total Revenue
  13.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Introduction
  13.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue in Human Microbiome Sequencing Business (2015-2020)
  13.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Development and Reaction to COVID-19
13.3 Charles River Laboratories International Inc.
  13.3.1 Charles River Laboratories International Inc. Company Details
  13.3.2 Charles River Laboratories International Inc. Business Overview and Its Total Revenue
  13.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Introduction
  13.3.4 Charles River Laboratories International Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  13.3.5 Charles River Laboratories International Inc. Recent Development and Reaction to COVID-19
13.4 Clinical Microbiomics A/S
  13.4.1 Clinical Microbiomics A/S Company Details
  13.4.2 Clinical Microbiomics A/S Business Overview and Its Total Revenue
  13.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Introduction
  13.4.4 Clinical Microbiomics A/S Revenue in Human Microbiome Sequencing Business (2015-2020)
  13.4.5 Clinical Microbiomics A/S Recent Development and Reaction to COVID-19
13.5 Eurofins Scientific SE
  13.5.1 Eurofins Scientific SE Company Details
  13.5.2 Eurofins Scientific SE Business Overview and Its Total Revenue
  13.5.3 Eurofins Scientific SE Human Microbiome Sequencing Introduction
  13.5.4 Eurofins Scientific SE Revenue in Human Microbiome Sequencing Business (2015-2020)
  13.5.5 Eurofins Scientific SE Recent Development and Reaction to COVID-19
13.6 GENEWIZ, Inc.
  13.6.1 GENEWIZ, Inc. Company Details
  13.6.2 GENEWIZ, Inc. Business Overview and Its Total Revenue
  13.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Introduction
  13.6.4 GENEWIZ, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  13.6.5 GENEWIZ, Inc. Recent Development and Reaction to COVID-19
13.7 Illumina, Inc.
  13.7.1 Illumina, Inc. Company Details
  13.7.2 Illumina, Inc. Business Overview and Its Total Revenue
  13.7.3 Illumina, Inc. Human Microbiome Sequencing Introduction
  13.7.4 Illumina, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  13.7.5 Illumina, Inc. Recent Development and Reaction to COVID-19
13.8 Novogene Corporation
  13.8.1 Novogene Corporation Company Details
  13.8.2 Novogene Corporation Business Overview and Its Total Revenue
  13.8.3 Novogene Corporation Human Microbiome Sequencing Introduction
  13.8.4 Novogene Corporation Revenue in Human Microbiome Sequencing Business (2015-2020)
  13.8.5 Novogene Corporation Recent Development and Reaction to COVID-19
13.9 OraSure Technologies, Inc.
  13.9.1 OraSure Technologies, Inc. Company Details
  13.9.2 OraSure Technologies, Inc. Business Overview and Its Total Revenue
  13.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Introduction
  13.9.4 OraSure Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  13.9.5 OraSure Technologies, Inc. Recent Development and Reaction to COVID-19
13.10 Oxford Nanopore Technologies, Inc.
  13.10.1 Oxford Nanopore Technologies, Inc. Company Details
  13.10.2 Oxford Nanopore Technologies, Inc. Business Overview and Its Total Revenue
  13.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Introduction
  13.10.4 Oxford Nanopore Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  13.10.5 Oxford Nanopore Technologies, Inc. Recent Development and Reaction to COVID-19
13.11 Pacific Biosciences of California, Inc.
  10.11.1 Pacific Biosciences of California, Inc. Company Details
  10.11.2 Pacific Biosciences of California, Inc. Business Overview and Its Total Revenue
  10.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Introduction
  10.11.4 Pacific Biosciences of California, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.11.5 Pacific Biosciences of California, Inc. Recent Development and Reaction to COVID-19
13.12 QIAGEN N.V.
  10.12.1 QIAGEN N.V. Company Details
  10.12.2 QIAGEN N.V. Business Overview and Its Total Revenue
  10.12.3 QIAGEN N.V. Human Microbiome Sequencing Introduction
  10.12.4 QIAGEN N.V. Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.12.5 QIAGEN N.V. Recent Development and Reaction to COVID-19
13.13 Second Genome, Inc.
  10.13.1 Second Genome, Inc. Company Details
  10.13.2 Second Genome, Inc. Business Overview and Its Total Revenue
  10.13.3 Second Genome, Inc. Human Microbiome Sequencing Introduction
  10.13.4 Second Genome, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.13.5 Second Genome, Inc. Recent Development and Reaction to COVID-19
13.14 Thermo Fisher Scientific Inc.
  10.14.1 Thermo Fisher Scientific Inc. Company Details
  10.14.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
  10.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Introduction
  10.14.4 Thermo Fisher Scientific Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.14.5 Thermo Fisher Scientific Inc. Recent Development and Reaction to COVID-19
13.15 Viome, Inc.
  10.15.1 Viome, Inc. Company Details
  10.15.2 Viome, Inc. Business Overview and Its Total Revenue
  10.15.3 Viome, Inc. Human Microbiome Sequencing Introduction
  10.15.4 Viome, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.15.5 Viome, Inc. Recent Development and Reaction to COVID-19
13.16 CosmosID
  10.16.1 CosmosID Company Details
  10.16.2 CosmosID Business Overview and Its Total Revenue
  10.16.3 CosmosID Human Microbiome Sequencing Introduction
  10.16.4 CosmosID Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.16.5 CosmosID Recent Development and Reaction to COVID-19
13.17 Leucine Rich Bio Pvt. Ltd.
  10.17.1 Leucine Rich Bio Pvt. Ltd. Company Details
  10.17.2 Leucine Rich Bio Pvt. Ltd. Business Overview and Its Total Revenue
  10.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Introduction
  10.17.4 Leucine Rich Bio Pvt. Ltd. Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.17.5 Leucine Rich Bio Pvt. Ltd. Recent Development and Reaction to COVID-19
13.18 Microba
  10.18.1 Microba Company Details
  10.18.2 Microba Business Overview and Its Total Revenue
  10.18.3 Microba Human Microbiome Sequencing Introduction
  10.18.4 Microba Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.18.5 Microba Recent Development and Reaction to COVID-19
13.19 Microbiome Insights Inc.
  10.19.1 Microbiome Insights Inc. Company Details
  10.19.2 Microbiome Insights Inc. Business Overview and Its Total Revenue
  10.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Introduction
  10.19.4 Microbiome Insights Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.19.5 Microbiome Insights Inc. Recent Development and Reaction to COVID-19
13.20 Molzym GmbH & Co. KG
  10.20.1 Molzym GmbH & Co. KG Company Details
  10.20.2 Molzym GmbH & Co. KG Business Overview and Its Total Revenue
  10.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Introduction
  10.20.4 Molzym GmbH & Co. KG Revenue in Human Microbiome Sequencing Business (2015-2020)
  10.20.5 Molzym GmbH & Co. KG Recent Development and Reaction to COVID-19

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Human Microbiome Sequencing Key Market Segments
Table 2. Key Players Covered: Ranking by Human Microbiome Sequencing Revenue
Table 3. Ranking of Global Top Human Microbiome Sequencing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Human Microbiome Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Next-Generation Sequencing
Table 6. Key Players of Traditional Sequencing Technologies
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Human Microbiome Sequencing Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Human Microbiome Sequencing Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Human Microbiome Sequencing Players to Combat Covid-19 Impact
Table 13. Global Human Microbiome Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Human Microbiome Sequencing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Human Microbiome Sequencing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Human Microbiome Sequencing Market Share by Regions (2015-2020)
Table 17. Global Human Microbiome Sequencing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Human Microbiome Sequencing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Human Microbiome Sequencing Market Growth Strategy
Table 23. Main Points Interviewed from Key Human Microbiome Sequencing Players
Table 24. Global Human Microbiome Sequencing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Human Microbiome Sequencing Market Share by Players (2015-2020)
Table 26. Global Top Human Microbiome Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Sequencing as of 2019)
Table 27. Global Human Microbiome Sequencing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Human Microbiome Sequencing Product Solution and Service
Table 30. Date of Enter into Human Microbiome Sequencing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Human Microbiome Sequencing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Human Microbiome Sequencing Market Size Share by Type (2015-2020)
Table 34. Global Human Microbiome Sequencing Revenue Market Share by Type (2021-2026)
Table 35. Global Human Microbiome Sequencing Market Size Share by Application (2015-2020)
Table 36. Global Human Microbiome Sequencing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Human Microbiome Sequencing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Human Microbiome Sequencing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Human Microbiome Sequencing Market Share (2019-2020)
Table 40. North America Human Microbiome Sequencing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Human Microbiome Sequencing Market Share by Type (2015-2020)
Table 42. North America Human Microbiome Sequencing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Human Microbiome Sequencing Market Share by Application (2015-2020)
Table 44. Europe Key Players Human Microbiome Sequencing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Human Microbiome Sequencing Market Share (2019-2020)
Table 46. Europe Human Microbiome Sequencing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Human Microbiome Sequencing Market Share by Type (2015-2020)
Table 48. Europe Human Microbiome Sequencing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Human Microbiome Sequencing Market Share by Application (2015-2020)
Table 50. China Key Players Human Microbiome Sequencing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Human Microbiome Sequencing Market Share (2019-2020)
Table 52. China Human Microbiome Sequencing Market Size by Type (2015-2020) (Million US$)
Table 53. China Human Microbiome Sequencing Market Share by Type (2015-2020)
Table 54. China Human Microbiome Sequencing Market Size by Application (2015-2020) (Million US$)
Table 55. China Human Microbiome Sequencing Market Share by Application (2015-2020)
Table 56. Japan Key Players Human Microbiome Sequencing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Human Microbiome Sequencing Market Share (2019-2020)
Table 58. Japan Human Microbiome Sequencing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Human Microbiome Sequencing Market Share by Type (2015-2020)
Table 60. Japan Human Microbiome Sequencing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Human Microbiome Sequencing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Human Microbiome Sequencing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Human Microbiome Sequencing Market Share (2019-2020)
Table 64. Southeast Asia Human Microbiome Sequencing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Human Microbiome Sequencing Market Share by Type (2015-2020)
Table 66. Southeast Asia Human Microbiome Sequencing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Human Microbiome Sequencing Market Share by Application (2015-2020)
Table 68. India Key Players Human Microbiome Sequencing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Human Microbiome Sequencing Market Share (2019-2020)
Table 70. India Human Microbiome Sequencing Market Size by Type (2015-2020) (Million US$)
Table 71. India Human Microbiome Sequencing Market Share by Type (2015-2020)
Table 72. India Human Microbiome Sequencing Market Size by Application (2015-2020) (Million US$)
Table 73. India Human Microbiome Sequencing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Human Microbiome Sequencing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Human Microbiome Sequencing Market Share (2019-2020)
Table 76. Central & South America Human Microbiome Sequencing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Human Microbiome Sequencing Market Share by Type (2015-2020)
Table 78. Central & South America Human Microbiome Sequencing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Human Microbiome Sequencing Market Share by Application (2015-2020)
Table 80. Baseclear B.V. Company Details
Table 81. Baseclear B.V. Business Overview
Table 82. Baseclear B.V. Product
Table 83. Baseclear B.V. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 84. Baseclear B.V. Recent Development
Table 85. Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Details
Table 86. Beijing Genomics Institute (BGI) Genomics Co., Ltd Business Overview
Table 87. Beijing Genomics Institute (BGI) Genomics Co., Ltd Product
Table 88. Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 89. Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Development
Table 90. Charles River Laboratories International Inc. Company Details
Table 91. Charles River Laboratories International Inc. Business Overview
Table 92. Charles River Laboratories International Inc. Product
Table 93. Charles River Laboratories International Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 94. Charles River Laboratories International Inc. Recent Development
Table 95. Clinical Microbiomics A/S Company Details
Table 96. Clinical Microbiomics A/S Business Overview
Table 97. Clinical Microbiomics A/S Product
Table 98. Clinical Microbiomics A/S Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 99. Clinical Microbiomics A/S Recent Development
Table 100. Eurofins Scientific SE Company Details
Table 101. Eurofins Scientific SE Business Overview
Table 102. Eurofins Scientific SE Product
Table 103. Eurofins Scientific SE Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 104. Eurofins Scientific SE Recent Development
Table 105. GENEWIZ, Inc. Company Details
Table 106. GENEWIZ, Inc. Business Overview
Table 107. GENEWIZ, Inc. Product
Table 108. GENEWIZ, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 109. GENEWIZ, Inc. Recent Development
Table 110. Illumina, Inc. Company Details
Table 111. Illumina, Inc. Business Overview
Table 112. Illumina, Inc. Product
Table 113. Illumina, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 114. Illumina, Inc. Recent Development
Table 115. Novogene Corporation Business Overview
Table 116. Novogene Corporation Product
Table 117. Novogene Corporation Company Details
Table 118. Novogene Corporation Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 119. Novogene Corporation Recent Development
Table 120. OraSure Technologies, Inc. Company Details
Table 121. OraSure Technologies, Inc. Business Overview
Table 122. OraSure Technologies, Inc. Product
Table 123. OraSure Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 124. OraSure Technologies, Inc. Recent Development
Table 125. Oxford Nanopore Technologies, Inc. Company Details
Table 126. Oxford Nanopore Technologies, Inc. Business Overview
Table 127. Oxford Nanopore Technologies, Inc. Product
Table 128. Oxford Nanopore Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 129. Oxford Nanopore Technologies, Inc. Recent Development
Table 130. Pacific Biosciences of California, Inc. Company Details
Table 131. Pacific Biosciences of California, Inc. Business Overview
Table 132. Pacific Biosciences of California, Inc. Product
Table 133. Pacific Biosciences of California, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 134. Pacific Biosciences of California, Inc. Recent Development
Table 135. QIAGEN N.V. Company Details
Table 136. QIAGEN N.V. Business Overview
Table 137. QIAGEN N.V. Product
Table 138. QIAGEN N.V. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 139. QIAGEN N.V. Recent Development
Table 140. Second Genome, Inc. Company Details
Table 141. Second Genome, Inc. Business Overview
Table 142. Second Genome, Inc. Product
Table 143. Second Genome, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 144. Second Genome, Inc. Recent Development
Table 145. Thermo Fisher Scientific Inc. Company Details
Table 146. Thermo Fisher Scientific Inc. Business Overview
Table 147. Thermo Fisher Scientific Inc. Product
Table 148. Thermo Fisher Scientific Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 149. Thermo Fisher Scientific Inc. Recent Development
Table 150. Viome, Inc. Company Details
Table 151. Viome, Inc. Business Overview
Table 152. Viome, Inc. Product
Table 153. Viome, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 154. Viome, Inc. Recent Development
Table 155. CosmosID Company Details
Table 156. CosmosID Business Overview
Table 157. CosmosID Product
Table 158. CosmosID Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 159. CosmosID Recent Development
Table 160. Leucine Rich Bio Pvt. Ltd. Company Details
Table 161. Leucine Rich Bio Pvt. Ltd. Business Overview
Table 162. Leucine Rich Bio Pvt. Ltd. Product
Table 163. Leucine Rich Bio Pvt. Ltd. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 164. Leucine Rich Bio Pvt. Ltd. Recent Development
Table 165. Microba Company Details
Table 166. Microba Business Overview
Table 167. Microba Product
Table 168. Microba Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 169. Microba Recent Development
Table 170. Microbiome Insights Inc. Company Details
Table 171. Microbiome Insights Inc. Business Overview
Table 172. Microbiome Insights Inc. Product
Table 173. Microbiome Insights Inc. Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 174. Microbiome Insights Inc. Recent Development
Table 175. Molzym GmbH & Co. KG Company Details
Table 176. Molzym GmbH & Co. KG Business Overview
Table 177. Molzym GmbH & Co. KG Product
Table 178. Molzym GmbH & Co. KG Revenue in Human Microbiome Sequencing Business (2015-2020) (Million US$)
Table 179. Molzym GmbH & Co. KG Recent Development
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Human Microbiome Sequencing Market Share by Type: 2020 VS 2026
Figure 2. Next-Generation Sequencing Features
Figure 3. Traditional Sequencing Technologies Features
Figure 4. Other Features
Figure 5. Global Human Microbiome Sequencing Market Share by Application: 2020 VS 2026
Figure 6. Genome Analysis Case Studies
Figure 7. Metabolome Analysis Case Studies
Figure 8. Transcriptome Analysis Case Studies
Figure 9. Other Omics Analysis Case Studies
Figure 10. Human Microbiome Sequencing Report Years Considered
Figure 11. Global Human Microbiome Sequencing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Human Microbiome Sequencing Market Share by Regions: 2020 VS 2026
Figure 13. Global Human Microbiome Sequencing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Human Microbiome Sequencing Market Share by Players in 2019
Figure 16. Global Top Human Microbiome Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Sequencing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Sequencing Revenue in 2019
Figure 18. North America Human Microbiome Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Human Microbiome Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Human Microbiome Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Human Microbiome Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Human Microbiome Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Human Microbiome Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Human Microbiome Sequencing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Baseclear B.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Baseclear B.V. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 27. Beijing Genomics Institute (BGI) Genomics Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 29. Charles River Laboratories International Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Charles River Laboratories International Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 31. Clinical Microbiomics A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Clinical Microbiomics A/S Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 33. Eurofins Scientific SE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eurofins Scientific SE Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 35. GENEWIZ, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. GENEWIZ, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 37. Illumina, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Illumina, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 39. Novogene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Novogene Corporation Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 41. OraSure Technologies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. OraSure Technologies, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 43. Oxford Nanopore Technologies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Oxford Nanopore Technologies, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 45. Pacific Biosciences of California, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Pacific Biosciences of California, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 47. QIAGEN N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. QIAGEN N.V. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 49. Second Genome, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Second Genome, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 51. Thermo Fisher Scientific Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Thermo Fisher Scientific Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 53. Viome, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Viome, Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 55. CosmosID Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. CosmosID Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 57. Leucine Rich Bio Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Leucine Rich Bio Pvt. Ltd. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 59. Microba Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Microba Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 61. Microbiome Insights Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Microbiome Insights Inc. Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 63. Molzym GmbH & Co. KG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Molzym GmbH & Co. KG Revenue Growth Rate in Human Microbiome Sequencing Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


More Publications